↓ Skip to main content

A randomized phase II study of letrozole vs. observation in patients with newly diagnosed uterine leiomyosarcoma (uLMS)

Overview of attention for article published in Gynecologic Oncology Reports, November 2018
Altmetric Badge

Mentioned by

twitter
2 X users

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
A randomized phase II study of letrozole vs. observation in patients with newly diagnosed uterine leiomyosarcoma (uLMS)
Published in
Gynecologic Oncology Reports, November 2018
DOI 10.1016/j.gore.2018.11.001
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 3 13%
Student > Postgraduate 3 13%
Professor 2 9%
Professor > Associate Professor 2 9%
Other 1 4%
Other 2 9%
Unknown 10 43%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 9 39%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Biochemistry, Genetics and Molecular Biology 1 4%
Unknown 12 52%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 December 2018.
All research outputs
#23,424,011
of 33,005,778 outputs
Outputs from Gynecologic Oncology Reports
#487
of 759 outputs
Outputs of similar age
#242,639
of 356,484 outputs
Outputs of similar age from Gynecologic Oncology Reports
#7
of 9 outputs
Altmetric has tracked 33,005,778 research outputs across all sources so far. This one is in the 20th percentile – i.e., 20% of other outputs scored the same or lower than it.
So far Altmetric has tracked 759 research outputs from this source. They receive a mean Attention Score of 4.8. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 356,484 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.